Your browser is no longer supported. Please, upgrade your browser.
HOOK HOOKIPA Pharma Inc. weekly Stock Chart
HOOK [NASD]
HOOKIPA Pharma Inc.
Index- P/E- EPS (ttm)-1.90 Insider Own0.30% Shs Outstand25.63M Perf Week-0.38%
Market Cap286.82M Forward P/E- EPS next Y-1.94 Insider Trans-18.87% Shs Float18.59M Perf Month-1.87%
Income-44.60M PEG- EPS next Q-0.47 Inst Own61.30% Short Float4.41% Perf Quarter16.78%
Sales13.40M P/S21.40 EPS this Y-277.10% Inst Trans0.08% Short Ratio11.00 Perf Half Y-23.23%
Book/sh4.25 P/B2.47 EPS next Y-3.80% ROA-29.80% Target Price- Perf Year58.28%
Cash/sh3.83 P/C2.74 EPS next 5Y4.80% ROE-36.50% 52W Range5.80 - 14.37 Perf YTD-14.06%
Dividend- P/FCF- EPS past 5Y- ROI-41.50% 52W High-26.84% Beta-
Dividend %- Quick Ratio7.80 Sales past 5Y- Gross Margin- 52W Low81.21% ATR0.76
Employees85 Current Ratio7.80 Sales Q/Q68.20% Oper. Margin- RSI (14)46.45 Volatility5.29% 6.87%
OptionableYes Debt/Eq0.04 EPS Q/Q-16.10% Profit Margin- Rel Volume0.40 Prev Close10.51
ShortableYes LT Debt/Eq0.04 EarningsMay 14 BMO Payout- Avg Volume74.62K Price10.51
Recom1.40 SMA20-1.41% SMA50-4.89% SMA2004.93% Volume0 Change0.00%
Sep-27-19Initiated H.C. Wainwright Buy $15
May-13-19Initiated RBC Capital Mkts Outperform $23
May-13-19Initiated BofA/Merrill Buy $17
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
07:00AM  
Jul-23-20 03:24PM  
Jun-22-20 07:15AM  
Jun-19-20 07:00AM  
Jun-17-20 07:00AM  
Jun-12-20 02:04PM  
Jun-11-20 08:34AM  
May-26-20 07:30AM  
May-17-20 09:31AM  
May-14-20 08:15AM  
07:00AM  
May-07-20 12:30PM  
May-04-20 07:00AM  
Apr-29-20 07:00AM  
Apr-21-20 07:00AM  
Apr-19-20 10:33AM  
Mar-19-20 07:00AM  
06:00AM  
Mar-10-20 08:15AM  
Feb-18-20 08:00AM  
Jan-15-20 09:53AM  
Jan-06-20 07:00AM  
Dec-30-19 07:30AM  
Dec-20-19 02:27PM  
Nov-25-19 08:00AM  
Nov-12-19 04:01PM  
Nov-04-19 08:00AM  
Oct-31-19 08:15AM  
Sep-25-19 08:30AM  
Sep-19-19 08:55AM  
Aug-29-19 08:30AM  
Aug-12-19 04:01PM  
Jul-19-19 01:37PM  
Jul-17-19 10:06AM  
Jul-12-19 07:58AM  
07:24AM  
Jul-11-19 04:37PM  
04:01PM  
02:05PM  
Jun-10-19 09:10AM  
May-20-19 04:01PM  
May-08-19 03:47AM  
Apr-25-19 08:30AM  
Apr-18-19 11:01AM  
07:26AM  
Apr-17-19 10:49PM  
Apr-14-19 09:53AM  
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SOFINNOVA CAPITAL VI FCPR10% OwnerJul 20Sale11.9412,483149,1023,948,091Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJun 29Sale11.783,28038,6283,960,574Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJun 29Sale11.783,28038,6283,960,574Jul 01 04:16 PM
Matushansky IgorChief Medical OfficerJan 29Sale12.735,50069,99253,398Jan 31 04:01 PM
Lilja AndersSr. VP, Technical DevelopmentJan 23Option Exercise0.1011,6431,1647,568Jan 27 04:52 PM
Lilja AndersSr. VP, Technical DevelopmentJan 23Sale12.5911,643146,5330Jan 27 04:52 PM
Orlinger KlausSr. VP, ResearchJan 21Option Exercise0.106,7896796,789Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 21Sale12.026,78981,5920Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 16Option Exercise0.101,7111711,711Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 16Sale11.561,71119,7810Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 14Option Exercise0.108,5008508,500Jan 16 04:06 PM
Orlinger KlausSr. VP, ResearchJan 14Sale11.308,50096,0530Jan 16 04:06 PM
Matushansky IgorChief Medical OfficerDec 19Option Exercise0.1025,8912,58969,302Dec 23 08:30 AM
Matushansky IgorChief Medical OfficerDec 19Sale9.9310,404103,31258,898Dec 23 08:30 AM
Matushansky IgorChief Medical OfficerDec 17Option Exercise0.1026,3122,63154,895Dec 19 04:03 PM
Matushansky IgorChief Medical OfficerDec 17Sale7.8711,48490,37943,411Dec 19 04:03 PM